Intranasal opioid compositions
US8198291B2 · kind B2 · utility
9Cited by
51References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 7, 2010 |
| Grant date | Jun 12, 2012 |
| Priority date | — |
| Expiry date | Apr 7, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions for intranasal administration to a mammal that contain an effective amount of an opioid, a liquid nasal carrier for the opioid, and optionally a sweetener, flavoring agent or masking agent. In some embodiments of the present invention, the pharmaceutical compositions have improved bioavailability. In other embodiments of the present invention, the opioid compositions improve patient compliance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.